![Dawn Schottlandt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dawn Schottlandt
Investor Relations Contact at
GERON CORPORATION
Profile
Dawn Schottlandt is Senior VP-Corporate Affairs & Investor Relations at Geron Corp.
since 2025.
Formerly, Ms. Schottlandt was VP-Investor Relations & Corporate Communications at Chiasma, Inc. from 2019 to 2020 and VP-Investor Relations & Corporate Communications at ArQule, Inc. from 2015 to 2018.
Education includes undergraduate studies at Boston College.
Dawn Schottlandt active positions
| Companies | Position | Start |
|---|---|---|
| GERON CORPORATION | Investor Relations Contact | 01/10/2025 |
Former positions of Dawn Schottlandt
| Companies | Position | End |
|---|---|---|
| CHIASMA, INC. | Investor Relations Contact | 01/07/2020 |
| ARQULE, INC. | Investor Relations Contact | 01/01/2018 |
Training of Dawn Schottlandt
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
6
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Geron Corp.
 Geron Corp. BiotechnologyHealth Technology Discovers and develops therapeutic products for cancer | Health Technology |
ArQule, Inc.
 ArQule, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches and develops therapeutics to treat cancers & rare diseases | Health Technology |
Chiasma, Inc.
 Chiasma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops treatments for rare and serious chronic disease | Health Technology |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Dawn Schottlandt
Choose MarketScreener 
